Side-by-side comparison of AI visibility scores, market position, and capabilities
Richmond VA regulated utility (NYSE: D); $50.1B five-year capital plan (2025-2029, $17B data center driven), 33 GW → 47 GW contracted data center in NoVA, CVOW offshore wind, competing with Duke Energy.
Dominion Energy, Inc. is a Richmond, Virginia-based regulated electric and natural gas utility holding company — publicly traded on the New York Stock Exchange (NYSE: D) as an S&P 500 Utilities component — serving approximately 4.4 million electric customers in Virginia, North Carolina, and South Carolina through Dominion Energy Virginia (Virginia Electric and Power Company) and Dominion Energy South Carolina, and approximately 500,000 gas customers through Dominion Energy South Carolina Gas through approximately 16,500 employees. Dominion unveiled an ambitious $50.1 billion five-year capital investment plan for 2025-2029 — representing a $17 billion increase from prior plans specifically to support data center infrastructure in Virginia, where contracted data center capacity grew from 33 gigawatts to 47 gigawatts by October 2025 as hyperscale AI data center buildout in Northern Virginia (Ashburn/Loudoun County corridor — the world's largest data center market) accelerated beyond all prior demand projections. CEO Robert Blue's strategy reflects the unprecedented scale of AI-driven electricity demand growth in Dominion's Virginia service territory — where Amazon Web Services, Microsoft Azure, Google Cloud, and Meta have concentrated their largest data center campuses due to favorable regulatory environment, fiber infrastructure, and utility reliability. The $50.1 billion capital plan funds new generation capacity (solar, natural gas peakers, and potential nuclear uprates), transmission expansion to serve new data center substations, and distribution system upgrades across the Virginia service territory.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.